Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: Enhanced IL-13 production by IL-4-primed human mast cells

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 3, 1998, Pages 491-502

  Toru, Hano ^a   Pawankar, Ruby ^b,c   Ra, Chisel ^b   Yata, Junichi ^a   Nakahata, Tatsutoshi ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allergy; Fc RI . Chain; HMC 1; ICAM 1; IgE; IL 13; IL 4; KU812F; LFA 1; SCF

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4;

ALLERGIC REACTION; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL FUNCTION; CROSS LINKING; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTOPOIESIS; MAST CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031707007     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70140-X     Document Type: Article

References (54)

1. Young JD, Liu C, Butler G, Cohn ZA, Galli SJ. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci USA 1987;84:9175-9.
2. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 1989;339:64-7.
3. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor mediated activation. Nature 1989;339:150-2.
4. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990;346:274-6.
5. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
6. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995;181:1373-80.
7. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
8. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-65.
9. Möller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
10. Steffen M, Abboud M, Potter GK, Yung YP, Moore MA. Presence of tumor necrosis factor or a related factor in human basophil/mast cells. Immunology 1989;66:445-50.
11. Pawankar R, Okuda M, Hasegawa S, Suzuki K, Okubo K, Okumura K, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
12. Jaffe JS, Raible DG, Post TJ, Wang Y, Glaum MC, Butterfield JH, et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am J Respir Cell Mol Biol 1996;15:473-81.
13. Butterfield JH, Weilner D, Dewald G, Gleich GH. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.
14. Nilsson TB, Kusche-Gullberg M, Kjellén L, Butterfield JH, Sundström C, Nilsson K, et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 1994;39:489-98.
15. Nakahata T, Tsuji K, Tanaka R, Muraoka K, Okumura N, Sawai N, et al. Synergy of stem cell factor and other cytokines in mast cell development. In: Kitamura Y, Yamamoto S, Galli SJ, Greaves MW, editors. Biological and molecular aspects of mast cell and basophil differentiation and function. New York: Raven Press; 1995. p. 13-24.
16. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. IL-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998;1:187-95.
17. Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, et al. Tumor necrosis factor α. and interleukin-1 β expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 1993;21:1271-5.
18. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T. Induction of the high-affinity IgE receptor (FcεRI) on human mast cells by IL-4. Int Immunol 1996;8:1367-73.
19. Toru H, Kinashi T, Ra C, Nonoyama S, Yata J, Nakahata T. IL-4 induces homotypic aggregation of human cultured mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 1997;89:3296-302.
20. Kishi K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 1985;9:381-90.
21. Marlin SD, Springer TA. Purified intercellular adhesion molecules (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-9.
22. Ra C, Kuromitsu S, Hirose T, Yasuda S, Furuishi K, Okumura K. Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. Int Immunol 1993;5:47-54.
23. Yanagihara Y, Kajiwara K, Ikizawa K, Koshio T, Okumura K, Ra C. Recombinant soluble form of the human high-affinity immunoglobulin E (IgE) receptor inhibits IgE production through its specific binding to IgE-bearing B cells. J Clin Invest 1994;94:2162-5.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Smith TJ, Ducharme LA, Weis JH. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol 1994;24:822-6.
26. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor, a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989;170:827-45.
27. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PE, Wolitzky AG, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
28. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, et al. Production of natural killer stimulatory factor (IL-12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
29. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
30. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-4.
31. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993;90:3735-9.
32. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1993;151:6370-81.
33. Defrance T, Carayon P, Billian G, Guillemot J, Minty A, Caput D, et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994;179:135-43.
34. Punnonen J, de Vries JE. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J Immunol 1994;152:1094-102.
35. Cocks BG, de Waal Malefyt R, Galizzi J, deVries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993;5:657-63.
36. Zurawski G, De Vries JE. Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
37. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
38. Dvorak AM. Human mast cells, ultrastructural observation of in situ, ex vivo, and in vitro sites, sources, and systems. In: Kaliner MA, Metcalfe DD, editors. The mast cell in health and disease. New York: Marcel Dekker, Inc; 1993. p. 1.
39. Mitui H, Furitsu T, Dvorak AM, Irani AAM, Schwartz LB, Inagaki N, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 1993;90:735-9.
40. Durand B, Migliacco G, Yee NS, Eddleman K, Huima-Byron T, Migliaccio AR, et al. Long-term generation of human mast cells in serum free-cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood 1994;84:3667-74.
41. Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992;80:3009-21.
42. Xia H-Z, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, et al. Effect of recombinant human IL-4 on tryptase, chymase, and Fee receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 1997;159:2911-21.
43. Banks EMS, Coleman JW. A comparative study of peritoneal mast cells from mutant IL-4 deficient and normal mice: evidence that IL-4 is not essential for mast cell development but enhances secretion via control of IgE binding and passive sensitization. Cytokine 1995;8:190-6.
44. Gupta AA, Leal-Berumen I, Croitoru K, Marshall JS. Rat peritoneal mast cells produce IFN-γ following IL-12 treatment but not in response to IgE-mediated activation. J Immunol 1996;157:2123-8.
45. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993;12:2663-70.
46. Callard RE, Matthews DJ, Hibbert L. IL-4 and IL-13 receptors: Are they one and the same? Immunol Today 1996;17:108-10.
47. Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F, Zurawski S, et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993;178:2213-8.
48. Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O'Shea JJ, et al. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc Natl Acad Sci USA 1995;92:7681-5.
49. Welham MJ, Learmonth L, Bone H, Schrader JW. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 1995;270:12286-96.
50. Hilton DJ, Zhang J, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996;93:497-501.
51. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterizaion of the human interleukin 13 receptor α chain. J Biol Chem 1996;271:29265-70.
52. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, et al. Cloning and characterizaion of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α. chain. J Biol Chem 1996;271:16921-6.
53. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, et al. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 1996;271:619-22.
54. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL13 and IL-15. Immunity 1995;2:331-9.